{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:52:17Z","timestamp":1790801537622,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40272-021-00440-8","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T07:03:07Z","timestamp":1616569387000},"page":"131-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Paradoxical Psoriasis in Children Receiving Anti-TNF\u03b1 Treatment for Inflammatory\/autoimmune Disease"],"prefix":"10.1007","volume":"23","author":[{"given":"Natalie","family":"Rosenwasser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sidbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3618-1379","authenticated-orcid":false,"given":"Yongdong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,24]]},"reference":[{"key":"440_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jaad.2016.08.012","volume":"76","author":"G Brown","year":"2017","unstructured":"Brown G, Wang E, Leon A, Huynh M, Wehner M, Matro R, et al. Tumor necrosis factor-\u03b1 inhibitor-induced psoriasis: systematic review of clinical features, histopathological findings, and management experience. J Am Acad Dermatol. 2017;76:334\u201341.","journal-title":"J Am Acad Dermatol."},{"key":"440_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41467-017-02466-4","volume":"9","author":"C Conrad","year":"2018","unstructured":"Conrad C, Di Domizio J, Mylonas A, et al. TNF Blockade Induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis. Nat Commun. 2018;9:25. https:\/\/doi.org\/10.1038\/s41467-017-02466-4.","journal-title":"Nat Commun"},{"key":"440_CR3","first-page":"223","volume":"143","author":"GC de Gannes","year":"2007","unstructured":"de Gannes GC, Ghoreishi M, Pope J, Russell A, Bell D, Adams S, et al. Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol United States. 2007;143:223\u201331.","journal-title":"Arch Dermatol United States"},{"key":"440_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/rheumatology\/keh437","volume":"44","author":"D Aeberli","year":"2005","unstructured":"Aeberli D, Seitz M, J\u00fcni P, Villiger PM. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors. Rheumatology (Oxford) England. 2005;44:172\u20135.","journal-title":"Rheumatology (Oxford) England"},{"key":"440_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/gutjnl-2012-302853","volume":"63","author":"C Tillack","year":"2014","unstructured":"Tillack C, Ehmann LM, Friedrich M, Laubender RP, Papay P, Vogelsang H, et al. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-\u03b3-expressing Th1 cells and IL-17A\/IL-22-expressing Th17 cells and respond to anti-IL-12\/IL-23 antibody treatment. Gut. 2014;63:567\u201377.","journal-title":"Gut"},{"key":"440_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24100","author":"LH Buckley","year":"2019","unstructured":"Buckley LH, Xiao R, Perman MJ, Grossman AB, Weiss PF. Psoriasis associated with tumor necrosis factor-alpha inhibitors in children with inflammatory diseases. Arthritis Care Res (Hoboken). 2019. https:\/\/doi.org\/10.1002\/acr.24100.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"suppl 1","key":"440_CR7","first-page":"232","volume":"72","author":"S Kodama","year":"2020","unstructured":"Kodama S, Gupta D, Sullivan E, Zhao Y. Prevalence of paradoxical psoriasis after exposure to tumor necrosis factor inhibitors (TNFi) in children from a single tertiary center [abstract]. Arthritis Rheumatol. 2020;72(suppl 1):232\u20133.","journal-title":"Arthritis Rheumatol."},{"key":"440_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1525-1470.2011.01521.x","volume":"29","author":"MJ Perman","year":"2012","unstructured":"Perman MJ, Lovell DJ, Denson LA, Farrell MK, Lucky AW. Five cases of anti-tumor necrosis factor alpha-induced psoriasis presenting with severe scalp involvement in children. Pediatr Dermatol. 2012;29:454\u20139.","journal-title":"Pediatr Dermatol"},{"key":"440_CR9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jdcr.2018.06.008","volume":"4","author":"JA Campbell","year":"2018","unstructured":"Campbell JA, Kodama SS, Gupta D, Zhao Y. Case series of psoriasis associated with tumor necrosis factor-\u03b1 inhibitors in children with chronic recurrent multifocal osteomyelitis. JAAD Case Reports. 2018;4:767\u201371.","journal-title":"JAAD Case Reports"},{"key":"440_CR10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/pde.13859","volume":"36","author":"D Groth","year":"2019","unstructured":"Groth D, Perez M, Treat JR, Castelo-Soccio L, Nativ S, Weiss PF, et al. Tumor necrosis factor-\u03b1 inhibitor-induced psoriasis in juvenile idiopathic arthritis patients. Pediatr Dermatol. 2019;36:613\u20137.","journal-title":"Pediatr Dermatol"},{"key":"440_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/MPG.0b013e31828390ba","volume":"56","author":"ME Sherlock","year":"2013","unstructured":"Sherlock ME, Walters T, Tabbers MM, Frost K, Zachos M, Muise A, et al. Infliximab-induced psoriasis and psoriasiform skin lesions in pediatric Crohn disease and a potential association with IL-23 receptor polymorphisms. J Pediatr Gastroenterol Nutr. 2013;56:512\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"440_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/pde.13081","volume":"34","author":"JB Eickstaedt","year":"2017","unstructured":"Eickstaedt JB, Killpack L, Tung J, Davis D, Hand JL, Tollefson MM. Psoriasis and psoriasiform eruptions in pediatric patients with inflammatory bowel disease treated with anti-tumor necrosis factor alpha agents. Pediatr Dermatol. 2017;34:253\u201360.","journal-title":"Pediatr Dermatol"},{"key":"440_CR13","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1097\/MIB.0000000000000088","volume":"20","author":"T M\u00e4lk\u00f6nen","year":"2014","unstructured":"M\u00e4lk\u00f6nen T, Wikstr\u00f6m A, Heiskanen K, Merras-Salmio L, Mustonen H, Sipponen T, et al. Skin reactions during anti-TNF\u03b1 therapy for pediatric inflammatory bowel disease: a 2-year prospective study. Inflamm Bowel Dis. 2014;20:1309\u201315.","journal-title":"Inflamm Bowel Dis"},{"key":"440_CR14","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jaad.2009.07.029","volume":"62","author":"MM Tollefson","year":"2010","unstructured":"Tollefson MM, Crowson CS, McEvoy MTMKH. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2010;62:979\u201387.","journal-title":"J Am Acad Dermatol"},{"key":"440_CR15","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1111\/pde.12820","volume":"33","author":"R Romiti","year":"2016","unstructured":"Romiti R, Araujo KM, Steinwurz F, Denadai R. Anti-tumor necrosis factor \u03b1-related psoriatic lesions in children with inflammatory bowel disease: case report and systematic literature review. Pediatr Dermatol. 2016;33:e174\u20138.","journal-title":"Pediatr Dermatol"},{"key":"440_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-017-8642-3","volume":"56","author":"M Cattalini","year":"2019","unstructured":"Cattalini M, Soliani M, Caparello MCCR. Sex differences in pediatric rheumatology. Clin Rev Allergy Immunol. 2019;56:293\u2013307. https:\/\/doi.org\/10.1007\/s12016-017-8642-3.","journal-title":"Clin Rev Allergy Immunol"},{"key":"440_CR17","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/art.39013","volume":"67","author":"J Wipff","year":"2015","unstructured":"Wipff J, Costantino F, Lemelle I, Pajot C, Duquesne A, Lorrot M, et al. A large national cohort of French patients with chronic recurrent multifocal osteitis. Arthritis Rheumatol. 2015;67:1128\u201337.","journal-title":"Arthritis Rheumatol"},{"key":"440_CR18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/rheumatology\/kel190","volume":"46","author":"A Jansson","year":"2007","unstructured":"Jansson A, Renner ED, Ramser J, Mayer A, Haban M, Meindl A, et al. Classification of non-bacterial osteitis: Retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology. 2007;46:154\u201360.","journal-title":"Rheumatology"},{"key":"440_CR19","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s00296-016-3572-6","volume":"36","author":"A Schnabel","year":"2016","unstructured":"Schnabel A, Range U, Hahn G, Siepmann T, Berner R, Hedrich CM. Unexpectedly high incidences of chronic non-bacterial as compared to bacterial osteomyelitis in children. Rheumatol Int Springer, Berlin Heidelberg. 2016;36:1737\u201345 (Epub 2016 Oct 11).","journal-title":"Rheumatol Int Springer, Berlin Heidelberg"},{"key":"440_CR20","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/rheumatology\/key143","volume":"57","author":"H Girschick","year":"2018","unstructured":"Girschick H, Finetti M, Orlando F, Schalm S, Insalaco A, Ganser G, et al. The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry. Rheumatology. 2018;57:1504.","journal-title":"Rheumatology"},{"key":"440_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18122526","volume":"18","author":"F Capon","year":"2017","unstructured":"Capon F. The genetic basis of psoriasis. Int J Mol Sci. 2017;18:1\u20139.","journal-title":"Int J Mol Sci"},{"key":"440_CR22","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/art.23835","volume":"59","author":"AN Collamer","year":"2008","unstructured":"Collamer AN, Guerrero KT, Henning JS, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum. 2008;59:996\u20131001.","journal-title":"Arthritis Rheum"},{"key":"440_CR23","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jaad.2020.01.061","volume":"82","author":"A Menter","year":"2020","unstructured":"Menter A, Cordoro KM, Davis DMR, et al. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020;82:574.","journal-title":"J Am Acad Dermatol"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-021-00440-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-021-00440-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-021-00440-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T02:11:21Z","timestamp":1616811081000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-021-00440-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["440"],"URL":"https:\/\/doi.org\/10.1007\/s40272-021-00440-8","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"8 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Approved.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"NR, YZ, RS, and DL have contributed to this review.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}